title: Role of tachykinins and neurokinin receptor subtypes in the regulation of motility of the forestomach and abomasum in conscious sheep.
abstract: The present study was planned to evaluate role of tachykinins (TKs) and neurokinin (NK) receptors in the regulation of gastric motility in sheep. We examined the effects of intravenous (i.v.) injection of neurokinin A (NKA) and substance P (SP) on motility of the rumen, omasum, and abomasum in conscious sheep and the effects of NK receptor blockade on the effect of TKs using NK-1 receptor antagonist L-732,138 and NK-2 receptor antagonist SR48968. Moreover, the effect of NK receptor blockade on omasal cyclic contractions was examined. Intravenous injection of NKA and SP induced tonic contraction of rumen, omasum, and abomasum, and the contractile effect of NKA was more potent than that of SP in all the gastric regions. Although the effect of SP was not inhibited by L-732,138, the effect of NKA was significantly inhibited by SR48968. However, single infusion of SR48968 and L-732,138 did not alter cyclic electromyographic activity and basal intraluminal pressure in the omasum. These results imply that NKA and NK-2 receptors play a primary role in non-cholinergic regulation of ovine gastric motility, though NK-2 and NK-1 receptors seem unlikely to be involved in the physiological regulation of omasal cyclic contractions.
authors.affiliation: Laboratory of Veterinary Physiology, Department of Biosciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.
authors.forename: Taro
authors.initials: T
authors.lastname: Oh-ishi
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Shimoda
authors.forename: Hideaki
authors.initials: H
authors.lastname: Hayashi
authors.forename: Takenori
authors.initials: T
authors.lastname: Onaga
mesh_terms: D000018:Abomasum / Q000187:drug effects*; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D009119:Muscle Contraction / Q000502:physiology; D015288:Neurokinin A / Q000008:administration & dosage / Q000494:pharmacology; D009851:Omasum / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000502:physiology*; D012417:Rumen / Q000187:drug effects*; D012756:Sheep; D013373:Substance P / Q000494:pharmacology; D015320:Tachykinins / Q000502:physiology*; D014364:Tryptophan / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D001549:Benzamides; D010880:Piperidines; D018041:Receptors, Neurokinin-2; D015320:Tachykinins; C086089:3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan; D013373:Substance P; C073839:SR 48968; D015288:Neurokinin A; D014364:Tryptophan